Latest News
Voyager Therapeutics, Inc.
- Voyager Therapeutics, Inc. Estimates – HAM:VT6
- Al Sandrock to step down as Voyager CEO; Insmed adds Paul Hudson to board
- Voyager Therapeutics CEO Al Sandrock to step down after Alzheimer's trial data
- Voyager Therapeutics Names Robin Swartz President, Plans CEO Transition in 2027
- Voyager Therapeutics appoints Robin Swartz as president, outlines CEO succession plan
- Voyager Therapeutics names Robin Swartz as president By Investing.com
- Form 8K Voyager Therapeutics Inc For: 21 October By Investing.com
- Robin Swartz Appointed President of Voyager Therapeutics with CEO Succession Planned for 2027
- Voyager Announces CEO Succession Plan, Appoints Robin Swartz President
- Voyager Therapeutics stock trades at EUR 1.80 as revenue falls to USD 3.17 million
- Voyager Therapeutics (VYGR) Slips 7.35% to $2.27 as Selling Pressure Builds - Social Sentiment
- Companies Like Voyager Therapeutics (NASDAQ:VYGR) Could Be Quite Risky
Headlines from the last 30 days, linking to the original publishers. See all market news →